GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » H U Group Holdings Inc (TSE:4544) » Definitions » EBITDA Margin %

H U Group Holdings (TSE:4544) EBITDA Margin % : 3.91% (As of Sep. 2024)


View and export this data going back to 1983. Start your Free Trial

What is H U Group Holdings EBITDA Margin %?

EBITDA Margin % is calculated as EBITDA divided by its Revenue. H U Group Holdings's EBITDA for the three months ended in Sep. 2024 was 円2,365 Mil. H U Group Holdings's Revenue for the three months ended in Sep. 2024 was 円60,520 Mil. Therefore, H U Group Holdings's EBITDA margin for the quarter that ended in Sep. 2024 was 3.91%.


H U Group Holdings EBITDA Margin % Historical Data

The historical data trend for H U Group Holdings's EBITDA Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

H U Group Holdings EBITDA Margin % Chart

H U Group Holdings Annual Data
Trend Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
EBITDA Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 9.37 15.08 20.64 16.47 5.76

H U Group Holdings Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
EBITDA Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 8.02 5.89 2.01 10.89 3.91

Competitive Comparison of H U Group Holdings's EBITDA Margin %

For the Diagnostics & Research subindustry, H U Group Holdings's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


H U Group Holdings's EBITDA Margin % Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, H U Group Holdings's EBITDA Margin % distribution charts can be found below:

* The bar in red indicates where H U Group Holdings's EBITDA Margin % falls into.



H U Group Holdings EBITDA Margin % Calculation

EBITDA margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent.

H U Group Holdings's EBITDA Margin % for the fiscal year that ended in Mar. 2024 is calculated as

EBITDA Margin %=EBITDA (A: Mar. 2024 )/Revenue (A: Mar. 2024 )
=13650/236950
=5.76 %

H U Group Holdings's EBITDA Margin % for the quarter that ended in Sep. 2024 is calculated as

EBITDA Margin %=EBITDA (Q: Sep. 2024 )/Revenue (Q: Sep. 2024 )
=2365/60520
=3.91 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


H U Group Holdings  (TSE:4544) EBITDA Margin % Explanation

EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.


H U Group Holdings EBITDA Margin % Related Terms

Thank you for viewing the detailed overview of H U Group Holdings's EBITDA Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


H U Group Holdings Business Description

Traded in Other Exchanges
N/A
Address
Shinjuku Mitsui Building, 2-1-1 Nishishinjuku, Shinjuku-ku, Tokyo, JPN, 163-0408
H U Group Holdings Inc operates in the healthcare field, focusing on clinical laboratory testing and reagents. The company is engaged in four main businesses. The Clinical Laboratory Testing Business receives samples taken from patients at medical institutions to test for the disease and confirm the condition of the patient's health; In Vitro Diagnostics develops, manufactures, and sells testing reagents and equipment inside and outside Japan; Sterilization & Related Services Business provides a range of medical-related services including sterilization; and Emerging New Business & Others is a new business for future growth.

H U Group Holdings Headlines

No Headlines